Specialty pharmacy workflows must account for longer, more complex affordability calls, with copay-shock interactions ...

On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...

Non-receipt of targeted and immunotherapies in diverse patients with metastatic cancers. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not include a ...

Copayment accumulators and maximizers have the potential to harm patients’ access to necessary medicines. Health care payers (including employers, insurers, and pharmacy benefit managers), regulators, ...

Receipt of FA significantly lowered annual OOP spending but did not significantly reduce the likelihood of catastrophic spending. Non-White patients and those who spoke English as a second language ...

Please provide your email address to receive an email when new articles are posted on . The programs are designed to provide anti-VEGF treatment for patients who are uninsured or underinsured.

In the rapidly evolving landscape of healthcare, Pharma Patient Assistance Programs (PAP) have been a lifeline for many patients seeking access to essential medications. These programs aim to help ...

When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass the insurer and access the drug at ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The high cost of prescription eye medications affects over 2 million Americans dealing with vision problems. Patient Assistance Programs (PAPs) offer a vital solution for the underinsured and ...

You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...

Ten case studies were conducted between December 2001 and March 2002 to identify critical issues to be explored more widely in a multistate telephone survey. The case-study sites were selected to ...